Client

Michelson Diagnostics Limited

Kent, United Kingdom

www.michelsondiagnostics.com

Back to Transactions

Synopsis

Client

Michelson Diagnostics Ltd., Kent, United Kingdom

Diagnostic imaging company focused on the diagnosis and treatment-management of a variety of skin conditions.  Utilizing multi-beam optical coherence tomography (“OCT”), the VivoSight device enables dermatologists to capture real-time, non-invasive, continuous, high-resolution images of the sub-surface of the skin.

Mandate

Shareholder rights issue to enable Michelson to file for US FDA 510(k) authorisation for 2nd generation VivoSight Dx OCT imaging device in the United States and further explore the use of VivoSight and the Dynamic OCT software in aesthetic dermatology.

Investor(s)

Octopus Ventures, Smith & Nephew, Kent County Council and angel investors

Transaction

£1,500,000 Series C

Our Role

Acted as financial advisor to the Board of Directors and management

  • Structured rights issue and approached lead investors to secure support.
  • Spearheaded negotiation on behalf of the Company with each investor class to complete the rights issue.